Edwards Lifesciences (EW) PT Lowered to $85 at Baird

April 15, 2026 6:26 AM

Baird analyst David Rescott lowered the price target on Edwards Lifesciences (NYSE: EW) to $85.00 (from $87.00) while maintaining a Neutral rating.

No results found